Preparation and Functional Evaluation of RGD-Modified Proteins as α<sub>v</sub>β<sub>3</sub> Integrin Directed TherapeuticsRobbert J. Kok, Grietje Molema, Astrid J. Schraa et al.|Bioconjugate Chemistry|2001Cited by 146
Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution studyAstrid J. Schraa, Grietje Molema, Robbert J. Kok et al.|International Journal of Cancer|2002Cited by 73
Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targetingAstrid J. Schraa, Grietje Molema, Agnes D. Berendsen et al.|Journal of Controlled Release|2002Cited by 64
LIGAND-TARGETED LIPOSOMES DIRECTED AGAINST PATHOLOGICAL VASCULATURERaymond M. Schiffelers, Gert Storm, Grietje Molema et al.|Journal of Liposome Research|2002Cited by 21
Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseasesAstrid J. Schraa, Grietje Molema, Maaike Everts et al.|Biotechnology annual review|2002Cited by 18